Par Pharmaceutical Companies (PRX)
Par Pharmaceutical Companies Income Statement
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Income | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Revenue | 271.47M | 253.64M | 215.36M | 224.19M | 232.95M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cost of Revenue | 164.80M | 150.33M | 130.25M | 125.16M | 120.54M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Gross Profit | 106.67M | 103.31M | 85.10M | 99.03M | 112.41M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Research & Development Expense | 29.90M | 18.14M | 9.61M | 8.077M | 10.71M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Selling, General, & Admin. Expense | 42.16M | 44.52M | 35.76M | 46.16M | 46.94M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation & Amortization | 8.822M | 10.34M | 2.761M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||
| Operating Interest Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Operating Income (Expense) | -2.00M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||||
| Total Operating Expenses | 247.68M | 223.34M | 175.62M | 206.38M | 180.96M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Operating Income | 23.79M | 30.31M | 39.73M | 17.81M | 52.00M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Non-Operating Income | -47.96M | -2.093M | 0.01M | 0.232M | -190.29M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Pretax Income | -24.17M | 28.21M | 39.74M | 18.04M | -138.29M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Provision for Income Taxes | 4.525M | -3.096M | 17.69M | 8.859M | -29.45M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Income after Tax | -28.70M | 31.31M | 22.06M | 9.18M | -108.84M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Equity In Affiliates | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income Before Extraordinaries & Disc. Operations | -28.70M | 31.31M | 22.06M | 9.18M | -108.84M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Investment Gains/Losses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Income/Charges | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income from Discontinued Operations | -0.027M | 20.54M | -0.127M | -0.127M | -0.127M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Income | -28.72M | 51.84M | 21.93M | 9.053M | -108.97M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Earnings Per Share Data | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Average Shares to compute diluted EPS | 36.30 | 35.95 | 36.77 | 36.71 | 35.50 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Average Shares used to compute basic EPS | 36.30 | 35.95 | 36.14 | 35.98 | 35.50 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Basic net | -0.79 | 1.48 | 0.61 | 0.25 | -3.07 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Diluted net | -0.79 | 1.49 | 0.60 | 0.25 | -3.07 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |